Inventor · disambiguated record
Lars Heslet
Also filed as: HESLET LARS
7 granted patents·15 pending applications·2 citations·filing 2005–2021
73Inventor score
Files withReponex Pharmaceuticals Aps10HESLET LARS4REPONEX PHARMACEUTICALS AS4APS REPONEX PHARMACEUTICALS1FIALA KAARE1
Top patents by PatentIndex Score
22 records- 0169US9855316B2Granulocyte-macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapyHESLET LARS·Filed 2012·Granted Jan 2, 2018·1 cites·15 claims
- 0264US7807639B2Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysisPHARMAORIGIN ASP·Filed 2006·Granted Oct 5, 2010·1 cites·17 claims
- 0361US2022218792A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2021·Application pending·0 cites
- 0460US11813309B2Method of alleviating chronic woundsReponex Pharmaceuticals Aps·Filed 2019·Granted Nov 14, 2023·0 cites·21 claims
- 0559US10716831B2Methods for inhibiting infectious peritonitisReponex Pharmaceuticals Aps·Filed 2018·Granted Jul 21, 2020·0 cites·17 claims
- 0656US2021121528A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2020·Application pending·0 cites
- 0754US2017095534A1Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunctionAPS REPONEX PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 0853US2014205658A1Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunctionHESLET LARS·Filed 2012·Application pending·0 cites
- 0951US2016256528A1Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunctionTRIFOILIUM APS·Filed 2015·Application pending·0 cites
- 1051US2020254062A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2019·Application pending·0 cites
- 1149US11426449B2Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapyREPONEX PHARMACEUTICALS AS·Filed 2017·Granted Aug 30, 2022·0 cites·4 claims
- 1248US8431535B2Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysisHESLET LARS·Filed 2005·Granted Apr 30, 2013·0 cites·14 claims
- 1348US2018289773A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2018·Application pending·0 cites
- 1443US2016000875A1Gm-csf for treatment of chronic oral mucositisReponex Pharmaceuticals Aps·Filed 2014·Application pending·0 cites
- 1541US2015174204A1Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthmaReponex Pharmaceuticals Aps·Filed 2013·Application pending·0 cites
- 1638US2016346354A1Compositions to promote the healing of skin ulcers and woundsReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 1738US2017035850A1Compositions for treating lung infections by airway administrationReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 1834US10105415B2Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel diseaseREPONEX PHARMACEUTICALS AS·Filed 2015·Granted Oct 23, 2018·0 cites·10 claims
- 1934US2017232069A1Compositions for the treatment of peritonitisReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 2032US2017182125A1Compositions for promoting the healing of woundsReponex Pharmaceuticals Aps·Filed 2015·Application pending·0 cites
- 2132US2013274171A1Trefoil factors (tff) for the treatment of chronic pulmonary diseasesFIALA KAARE·Filed 2011·Application pending·0 cites
- 2230US2013216608A1Airway Administration of Angiogenesis InhibitorsHESLET LARS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Heslet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →